Thursday, December 3 | 9:30 a.m.- 10:30 a.m. | R3-SSGI13-3 | Room E451B
Data from routine abdominal CT exams performed for other indications offer an opportunity to identify patients at risk for type 2 diabetes, according to this talk.
"[We found that] on non-contrast CT, abdominal biomarkers were associated with the risk and time to onset of type 2 diabetes," presenter Tejas Sudharshan Mathai, PhD of the National Institutes of Health in Bethesda, MD, and colleagues noted. "Increased adrenal volume, kidney volume, and pancreas attenuation heterogeneity, and decreased liver mean attenuation were strong predictors of future type 2 diabetes diagnosis."
Mathai's group conducted a study that included 8,992 adults who underwent routine non-contrast CT colonography between 2004 and 2016; patients with a type 2 diabetes diagnosis prior to baseline CT imaging were excluded. The researchers used both an AI model to obtain body composition biomarkers of muscle and fat (visceral and subcutaneous) and clinical variables such as age, sex, and body mass index (BMI). They evaluated five ways of assessing type 2 diabetes risk: clinical factors only; body composition; organ data; vascular data; and combined biomarkers.
The final, most effective model included age at CT, adrenal volume, kidney volume, liver mean attenuation, and pancreas attenuation heterogeneity. The group reported that greater age, adrenal volume, kidney volume and pancreas attenuation heterogeneity were all associated with higher risk of developing type 2 diabetes, while higher liver mean attenuation had a protective effect.
"Using biomarkers from routine abdominal CT conducted for other clinical indications presents an opportunity to identify undiagnosed patients at risk for type 2 diabetes and predict the time to disease onset," the investigators concluded.
Don't miss out on your opportunity to learn more about this research on Thursday morning.



